1. |
Varadkar S, Bien CG, Kruse CA, et al. Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. The Lancet Neurology, 2014, 13(2): 195-205.
|
2. |
Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain, 2005, 128(Pt 3): 454-471.
|
3. |
Jay V, Becker LE, Otsubo H, et al. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology, 1995, 45(1): 108-117.
|
4. |
Power C, Poland SD, Blume WT, et al. Cytomegalovirus and Rasmussen's encephalitis. Lancet, 1990, 336(8726): 1282-1284.
|
5. |
Wiendl H, Bien CG, Bernasconi P, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology, 2001, 57(8): 1511-1514.
|
6. |
Atkins MR, Terrell W, Hulette CM. Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol, 1995, 14(1): 7-12.
|
7. |
Pardo CA, Vining EP, Guo L, et al. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia, 2004, 45(5): 516-26.
|
8. |
Tang C, Yang W, Luan G. Progress in pathogenesis and therapy of Rasmussen's encephalitis. Acta Neurol Scand, 2022, 146(6): 761-766.
|
9. |
Bien CG, Urbach H, Deckert M, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology, 2002, 58(2): 250-257.
|
10. |
Schwab N, Bien CG, Waschbisch A, et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain, 2009, 132(Pt 5): 1236-1246.
|
11. |
Bauer J, Eiger CE, Hans VH, et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Annals of Neurology, 2007, 62(1): 67-80.
|
12. |
Schneider-Hohendorf T, Mohan H, Bien CG, et al. CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing. Nature Communications, 2016, 7: 145-152.
|
13. |
Troscher AR, Wimmer I, Quemada-Garrido L, et al. Microglial nodules provide the environment for pathogenic T cells in human encephalitis. Acta Neuropathologica, 2019, 137(4): 619-635.
|
14. |
Kebir H, Carmant L, Fontaine F, et al. Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis. Journal of Clinical Investigation, 2018, 128(5): 2000-2009.
|
15. |
Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol, 2002, 51(3): 311-318.
|
16. |
Di Liberto G, Pantelyushin S, Kreutzfeldt M, et al. Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping. Cell, 2018, 175(2): 458-471.
|
17. |
Takahashi Y, Mine J, Kubota Y, et al. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF. Epilepsia, 2009, 50(6): 1419-1431.
|
18. |
Owens GC, Huynh MN, Chang JW, et al. Differential expression of interferon-gamma and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Neuroinflammation, 2013, 10: 56.
|
19. |
Owens GC, Erickson KL, Malone CC, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation, 2015, 12: 134.
|
20. |
Dong C. Cytokine Regulation and Function in T Cells. Annu Rev Immunol, 2021, 39: 51-76.
|
21. |
Wirenfeldt M, Clare R, Tung S, et al. Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex. Neurobiol Dis, 2009, 34(3): 432-440.
|
22. |
Banati RB, Goerres GW, Myers R, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis. Neurology, 1999, 53(9): 2199-2199.
|
23. |
Eyo UB, Murugan M, Wu LJ. Microglia-Neuron Communication in Epilepsy. Glia, 2017, 65(1): 5-18.
|
24. |
Ramaswamy V, Walsh JG, Sinclair DB, et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis. J Neuroinflammation, 2013, 10: 152.
|
25. |
Tang C, Wang X, Deng J, et al. Increased inflammasome-activated pyroptosis mediated by caspase-1 in Rasmussen's encephalitis. Epilepsy Res, 2021, 179: 106843.
|
26. |
Cepeda C, Chang JW, Owens G C, et al. In Rasmussen encephalitis, hemichannels associated with microglial activation are linked to cortical pyramidal neuron coupling: a possible mechanism for cellular hyperexcitability. CNS Neurosci Ther, 2015, 21(2): 152-163.
|
27. |
Westfall JJ, Schwind WN, Sran S, et al. Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis. Acta Neuropathol Commun, 2022, 10(1): 168.
|
28. |
Leitner DF, Lin Z, Sawaged Z, et al. Brain molecular mechanisms in Rasmussen encephalitis. Epilepsia, 2023, 64(1): 218-230.
|
29. |
Manning T, Sontheimer HJG. Spontaneous intracellular calcium oscillations in cortical astrocytes from a patient with intractable childhood epilepsy (Rasmussen's encephalitis). Glia, 1997, 21(3): 332-337.
|
30. |
Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol, 2010, 119(1): 7-35.
|
31. |
Luan G, Gao Q, Guan Y, et al. Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol, 2013, 72(11): 1000-1008.
|
32. |
Luan G, Wang X, Gao Q, et al. Upregulation of Neuronal Adenosine A1 Receptor in Human Rasmussen Encephalitis. J Neuropathol Exp Neurol, 2017, 76(8): 720-731.
|
33. |
He X, Chen F, Zhang Y, et al. Upregulation of adenosine A2A receptor and downregulation of GLT1 is associated with neuronal cell death in Rasmussen's encephalitis. Brain Pathol, 2020, 30(2): 246-260.
|
34. |
Rasmussen T, Olszewski J, Lloydsmith D. Focal seizures due to chronic localized encephalitis. Neurology, 1958, 8(6): 435-445.
|
35. |
Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain, 2002, 125(Pt 8): 1751-1759.
|
36. |
Kruse CA, Pardo CA, Hartman AL, et al. Rasmussen encephalitis tissue transfer program. Epilepsia, 2016, 57(6): 1005-1007.
|